Liquidia
is a North Carolina-based biopharmaceutical company that researches and develops novel therapies for the treatment of pulmonary arterial hypertension... Read moreLiquidia
is a North Carolina-based biopharmaceutical company that researches and develops novel therapies for the treatment of pulmonary arterial hypertension... Read more
News
Regulatory
Mar 31, 2025
OINDPnews
FDA accepts Liquidia's resubmitted NDA for Yutrepia treprostinil DPI for the treatment of PAH and PH-ILD
Conference Presentation
Mar 27, 2025
Benzinga
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
Funding
Sep 12, 2024
Benzinga
Liquidia received $32.5M in Post-IPO Debt Funding
Liquidia Competitors
1
2
3
4
5
6
7
8
9
10